Sabcomeline
# Sabcomeline

Sabcomeline (Memric; SB-202,026) is a selective $M_1$ receptor partial agonist that was under development for the treatment of Alzheimer's disease. It made it to phase III clinical trials before being discontinued due to poor results.

